台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    96.1
  • 漲跌
    ▲0.9
  • 漲幅
    +0.95%
  • 成交量
    522
  • 產業
    上櫃 生技醫療類股
  • 306人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-凱基-士林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-士林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/09295.80295.6594.6001,3410.00%
2025/01/0700.001101.00101.50-11,275-0.08%
2025/01/0600.000.1101.00101.50-0.11,259-0.01%
2024/12/1600.003.187.3886.30-3.11,216-0.25%
2024/12/110.191.3000.0090.600.11,1930.01%
2024/12/09393.1000.0092.5031,1840.25%
2024/11/2500.00394.5093.80-31,079-0.28%
2024/11/22495.73193.8093.8031,0310.29%
2024/11/21195.8100.0096.2011,0210.10%
2024/11/2000.00397.2096.50-31,018-0.29%
2024/11/19397.4000.0096.0031,0150.30%
2024/11/141104.001102.50101.5009710.00%
2024/11/130104.0000.00106.5009460.00%
2024/11/085102.005101.50103.0008730.00%
2024/11/0700.007105.00103.50-7852-0.82%
2024/11/065102.501102.50102.5048260.48%
2024/11/0500.003106.50106.00-3782-0.38%
2024/11/041100.0000.00100.0017580.13%
2024/11/016105.337105.93105.00-1730-0.14%
2024/10/3000.001102.00102.00-1617-0.16%
2024/10/291100.001102.00100.5006040.00%
2024/10/282104.001100.50102.0015760.17%
2024/10/24297.85599.3498.30-3494-0.61%
2024/10/2300.00191.7093.70-1424-0.24%
2024/08/1900.00284.7084.50-2739-0.27%
2024/08/1600.00184.6084.60-1743-0.13%
2024/08/0900.000.285.4085.40-0.2783-0.03%
2024/07/31393.2000.0093.2037360.41%
2024/07/29195.0000.0094.5017360.14%
2024/07/2600.00196.8097.60-1729-0.14%
2024/07/1900.00597.2494.20-5708-0.71%
2024/07/17298.4000.0098.2026580.30%
2024/07/1500.00298.5098.40-2663-0.30%
2024/07/1100.00295.3095.20-2650-0.31%
2024/07/1000.00397.7096.60-3658-0.46%
2024/07/085100.005100.00100.5006550.00%
2024/07/02398.67299.0097.8016230.16%
2024/07/01298.001101.50101.0016100.16%
2024/06/28196.5000.0097.5015810.17%
2024/06/27597.0200.0095.7055820.86%
2024/06/26197.70397.7397.60-2576-0.35%
2024/06/2000.000.494.4094.50-0.4635-0.06%
2024/06/1900.00594.1093.80-5637-0.78%
2024/06/14595.54195.3095.3046550.61%
2024/06/1300.00496.9596.90-4651-0.61%
2024/06/11594.9200.0095.4056360.79%
2024/06/0500.00391.2092.90-3632-0.47%
2024/05/27190.8000.0091.7017760.13%
2024/05/2300.00293.8093.60-2842-0.24%
2024/05/22395.3300.0094.1038470.35%
2024/05/1700.00198.8097.90-1872-0.11%
2024/05/1400.00195.9094.30-11,043-0.10%
2024/05/0700.00192.8092.80-11,116-0.09%
2024/04/19189.1000.0089.0011,5230.07%
2024/04/1800.00292.7093.60-21,525-0.13%
2024/04/16292.1500.0091.0021,5570.13%
2024/04/1500.00295.6094.10-21,565-0.13%
2024/04/11298.3000.0097.9021,6150.12%
2024/04/09198.0000.0097.6011,7220.06%
2024/03/2500.00299.70101.00-21,816-0.11%
2024/03/20195.6000.0095.8011,8550.05%
2024/03/1500.000.693.3093.20-0.61,863-0.03%
2024/03/1400.00093.3092.7001,8820.00%
2024/03/13192.50194.7092.4001,8960.00%
2024/03/12395.9000.0095.6031,8890.16%
2024/03/08295.3500.0095.1021,9240.10%
2024/03/07397.6000.0099.3031,9300.16%
2024/03/06399.1700.0098.1031,9370.15%
2024/03/051100.5000.00100.5011,9140.05%
2024/02/264104.504104.50104.5001,9900.00%
2024/02/205101.0000.00101.5052,0580.24%
2024/02/155111.002.5110.62110.502.52,0600.12%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章